Cargando…
Reduced dose direct oral anticoagulants compared with warfarin with high time in therapeutic range in nonvalvular atrial fibrillation
Direct oral anticoagulants (DOACs) used in nonvalvular atrial fibrillation (NVAF) are dose-reduced in elderly and patients with impaired renal function. Only reduced dose dabigatran is concluded as having similar stroke risk reduction and lower risk of major bleeding than warfarin in the pivotal stu...
Autores principales: | Jansson, M., Själander, S., Sjögren, V., Björck, F., Renlund, H., Norrving, B., Själander, A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10110706/ https://www.ncbi.nlm.nih.gov/pubmed/36607464 http://dx.doi.org/10.1007/s11239-022-02763-w |
Ejemplares similares
-
Direct oral anticoagulants versus warfarin in patients with non-valvular atrial fibrillation and CKD G3–G5D
por: Welander, Frida, et al.
Publicado: (2023) -
Non-vitamin K oral anticoagulants are non-inferior for stroke prevention but cause fewer major bleedings than well-managed warfarin: A retrospective register study
por: Sjögren, Vilhelm, et al.
Publicado: (2017) -
Efficacy and safety of warfarin in patients with non-valvular atrial
fibrillation and CKD G3–G5D
por: Welander, Frida, et al.
Publicado: (2022) -
Bleeding risk in patients with venous thromboembolic events treated with new oral anticoagulants
por: Wallvik, Niklas, et al.
Publicado: (2020) -
Direct Oral Anticoagulants versus Warfarin in Octogenarians with Nonvalvular Atrial Fibrillation: A Systematic Review and Meta-Analysis
por: Bonanad, Clara, et al.
Publicado: (2021)